Significance of intraoperative use of pseudomonas aeruginosa injection for rapid recovery postoperative in thyroid cancer patients with central lymph node dissection: a randomized controlled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034086

Enrollment

Unknown

Registered

2020-06-23

Start date

2020-08-01

Completion date

Unknown

Last updated

2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid diseases

Interventions

Group A:Intraoperative use of pseudomonas aeruginosa injection (Unilaterality 0.5 ml, Bilaterality 1 ml)

Group B:Intraoperative use of saline solution

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with age between 18-80 years; 2. Sign the informed consent; 3. thyroid cancer patients with central lymph nodes dissection; 4. American Society of Anesthesiologists (ASA) scoring of 1 to 2.

Exclusion criteria

Exclusion criteria: 1. There is a clear history of allergy; 2. Unwillingness to participate.

Design outcomes

Primary

Measure	Time frame
length of stay postoperation;the total medical costs;Daily volume of drainage;Triglyceride levels (drainage liquid);Leucocyte levels;Red blood cell count (drainage liquid);condition of wound;	—

Secondary

Measure	Time frame
Daily body temperature;The score wound pain;	—

Countries

China

Contacts

Public ContactWei Tao

West China Hospital of Sichuan University

weihospitaltao@yeah.net+86 028-85423822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026